Gold tier status for patent prosecution by IAM Patent 1000 2024

We are proud to announce that we have received the prestigious Gold Tier Ranking for Patent Prosecution Firms in Australia, as recognised by IAM Patent 1000 for the year 2024. Our unique blend of technical expertise and client-focused service has consistently earned us this top-tier ranking year after year.

It is with great pleasure that we recognise the outstanding contributions of our leaders in the field. Congratulations to Brett Lunn, Connie Merlino, Ian Rourke, Jeremy Dobbin, Jenny Petering, John Landells, Karin Innes, Madeleine Kelly, Patrick McManamny, Rachel Hooke, Steve Gledhill in Australia; and Matt Adams in New Zealand for being named in IAM Patent 1000's recommended list for Patent Prosecution for 2024.

FB Rice and several members of our team members were honoured with a commendation in the IAM Patent 1000 2024:

IP specialist firm FB Rice helps leading innovators manage their intellectual property across the globe. The multi-talented patent group has a huge range of scientific expertise under its belt. It has recently expanded its reach to the other end of the Trans-Tasman Sea, and is now offering a full suite of IP services across the strait. The rainmaker here is Brett Lunn, a farsighted strategist and a highly regarded patent attorney. Biotechnology is a forte of Ian Rourke, Jenny Petering and Patrick McManamny. Biochemistry PhD Rourke undertook post-doctoral research at the clinical biochemistry department of the National University Hospital, Copenhagen; he joined the ensemble in 1998. Petering has made a name for herself in the biotechnology sphere, thanks to her top-class strategic portfolio management. Melbourne-based McManamny regularly counsels biotech companies in relation to the filing and management of international patent portfolios, FTO issues, patentability and due diligence. [Lee] Miles excels at coordinating prosecution of global patent portfolios as well as providing patentability, validity and FTO opinions. “Lee is very knowledgeable in the area and provides sound and objective advice.” Life sciences group leader Steve Gledhill draws upon his significant UK and EU experience to provide 360-degree patent protection for his discerning following. Previously on secondment to a multinational pharmaceutical company, Karin Innes has proved to be an invaluable asset to the practice when it comes to advising clients on patent strategy, patentability and infringement. Similarly fluent in the language of life sciences is John Landells. His practice focuses on the drafting of both local and foreign patent applications across a broad range of chemical-based technologies, including pharmaceuticals, veterinary therapeutics, electroactive materials, polymers and coatings, and food and dairy technologies. With more than 20 years in the patent space, Rachel Hooke steers the medical technology and China teams with a steady hand, while acting as co-leader of the engineering team. Next to her in the engineering group is Madeleine Kelly, who is a top pick among major players in the fintech, telecommunications, digital health and medical devices industries. Spearheading the registered design team in Sydney is Jeremy Dobbin, who specialises in patents and designs in the mechanical and electromechanical engineering fields. Known for her ability to quickly comprehend high-level mathematics and with extensive experience in application software, Connie Merlino captains the outfit’s computing and electronics team.

We extend our heartfelt thanks to our clients and team for their continuous support and dedication, which have been instrumental in helping us achieve this recognition. We look forward to another year of collective pursuit of excellence.